Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_assertion type Assertion NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_head.
- NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_assertion description "[To determine the prevalence of AKT E17K mutations in melanoma, the most aggressive form of skin cancer, we analysed 137 human melanoma specimens and 65 human melanoma cell lines for the previously described activating mutation of AKT1, and for analogous mutations in AKT2 and AKT3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_provenance.
- NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_assertion evidence source_evidence_literature NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_provenance.
- NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_assertion SIO_000772 18813315 NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_provenance.
- NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_assertion wasDerivedFrom befree-20140225 NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_provenance.
- NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_assertion wasGeneratedBy ECO_0000203 NP784003.RAkpfC-0MUFdlJfdkkBo1BhF5Qv9_0OY_r-lhkVgq1SA0130_provenance.